7. Tricyclic Antidepressants
Tricyclic antidepressants (TCAs), such as amitriptyline and nortriptyline, have anticholinergic properties that increase the risk of cognitive impairment and dementia, especially among older adults.
While effective for depression and certain neuropathic pain syndromes, TCAs are largely supplanted by selective serotonin reuptake inhibitors (SSRIs), which have a more favorable cognitive safety profile.
Patients currently taking TCAs should discuss potential risks and alternative medications with their prescriber, particularly if cognitive symptoms develop.
- Review antidepressant regimen regularly with your healthcare provider.
- Report memory changes or confusion promptly.
- Consider SSRIs or other non-anticholinergic options if appropriate.
8. Statins
Statins, including simvastatin and atorvastatin, are prescribed to lower cholesterol and reduce cardiovascular risk. Their impact on cognitive function remains controversial, with some studies reporting possible memory impairment while others suggest a protective effect against dementia.
Side effects such as muscle pain and gastrointestinal issues may indirectly affect quality of life. Patients should be closely monitored for any cognitive changes during statin therapy, and the decision to continue treatment should balance cardiovascular benefits against potential neurological risks.
- Report any new memory or mental confusion symptoms to your doctor.
- Do not discontinue statins without medical advice.
- Discuss the benefits and risks of statin therapy regularly.
